Historical record - last NADAC publication: 1/15/2021
Product Information
REBIF 22 MCG/0.5 ML SYRINGE is a brand product labeled by EMD Serono, Inc., priced at $1400.9343 per ML under NDC 44087002203. Its NADAC has been published 417 times since Jan 22, 2014.
Strength
22 ug/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087002203
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/15/2021
Active Ingredients
INTERFERON BETA-1AApproval Type
Biologic (BLA)
FDA Application
BLA103780On Market Since
3/7/2002
Pharmacological Classes
Price Statistics
The NADAC for REBIF 22 MCG/0.5 ML SYRINGE has been published 417 times since Jan 22, 2014, and over the history we have for it it has risen 83.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1400.9343 per ML |
|---|---|
| All-time high | $1400.9343 (Jan 12, 2022) |
| All-time low | $763.5440 (Jan 22, 2014) |
| Median price | $1085.2981 |
| Average price | $1094.2365 |
| Largest weekly change | +7.0% (Oct 15, 2014) |
| Weeks tracked | 417 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INTERFERON BETA-1A market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REBIF 22 MCG/0.5 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for REBIF 22 MCG/0.5 ML SYRINGE, manufactured by EMD Serono, Inc., is $1400.9343 per ML (NDC 44087002203), effective Jan 12, 2022.
How has the price of REBIF 22 MCG/0.5 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has risen 83.5%. It has been tracked across 417 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for REBIF 22 MCG/0.5 ML SYRINGE?
Since Jan 22, 2014, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has ranged from a low of $763.5440 (Jan 22, 2014) to a high of $1400.9343 (Jan 12, 2022), with a median of $1085.2981 per ML.
Are there cheaper alternatives to REBIF 22 MCG/0.5 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REBIF 22 MCG/0.5 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures REBIF 22 MCG/0.5 ML SYRINGE?
REBIF 22 MCG/0.5 ML SYRINGE (NDC 44087002203) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification